108 related articles for article (PubMed ID: 7499849)
1. Evaluation of loss and change of specificity resulting from random mutagenesis of an antibody VH region.
Casson LP; Manser T
J Immunol; 1995 Dec; 155(12):5647-54. PubMed ID: 7499849
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements for a specificity switch and for maintenance of affinity using mutational analysis of a phage-displayed anti-arsonate antibody of Fab heavy chain first complementarity-determining region.
Wong YW; Gill DS; Parhami-Seren B; Short MK; Sompuram SR; Margolies MN
J Immunol; 1998 Jun; 160(12):5990-7. PubMed ID: 9637513
[TBL] [Abstract][Full Text] [Related]
3. A single engineered amino acid substitution changes antibody fine specificity.
Kussie PH; Parhami-Seren B; Wysocki LJ; Margolies MN
J Immunol; 1994 Jan; 152(1):146-52. PubMed ID: 8254187
[TBL] [Abstract][Full Text] [Related]
4. Contribution of heavy chain junctional amino acid diversity to antibody affinity among p-azophenylarsonate-specific antibodies.
Parhami-Seren B; Margolies MN
J Immunol; 1996 Sep; 157(5):2066-72. PubMed ID: 8757328
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of H chain-associated idiotopes of anti-p-azophenylarsonate monoclonal antibodies.
Parhami-Seren B; Sharon J; Margolies MN
J Immunol; 1990 Jun; 144(11):4426-33. PubMed ID: 2111347
[TBL] [Abstract][Full Text] [Related]
6. The amino acid residues at the VH-D-JH junctions affect the affinity of anti-p-azophenylarsonate antibodies.
Parhami-Seren B; Wysocki L; Margolies MN
J Immunol; 1989 Dec; 143(12):4090-7. PubMed ID: 2512349
[TBL] [Abstract][Full Text] [Related]
7. Clustered H chain somatic mutations shared by anti-p-azophenylarsonate antibodies confer enhanced affinity and ablate the cross-reactive idiotype.
Parhami-Seren B; Wysocki LJ; Margolies MN; Sharon J
J Immunol; 1990 Oct; 145(7):2340-6. PubMed ID: 2118935
[TBL] [Abstract][Full Text] [Related]
8. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors.
Crouzier R; Martin T; Pasquali JL
J Immunol; 1995 May; 154(9):4526-35. PubMed ID: 7722307
[TBL] [Abstract][Full Text] [Related]
9. Affinity maturation of phage display antibody populations using ribosome display.
Groves M; Lane S; Douthwaite J; Lowne D; Rees DG; Edwards B; Jackson RH
J Immunol Methods; 2006 Jun; 313(1-2):129-39. PubMed ID: 16730741
[TBL] [Abstract][Full Text] [Related]
10. Affinity maturation of a V(H)H by mutational hotspot randomization.
Yau KY; Dubuc G; Li S; Hirama T; Mackenzie CR; Jermutus L; Hall JC; Tanha J
J Immunol Methods; 2005 Feb; 297(1-2):213-24. PubMed ID: 15777944
[TBL] [Abstract][Full Text] [Related]
11. Random mutagenesis of two complementarity determining region amino acids yields an unexpectedly high frequency of antibodies with increased affinity for both cognate antigen and autoantigen.
Casson LP; Manser T
J Exp Med; 1995 Sep; 182(3):743-50. PubMed ID: 7650481
[TBL] [Abstract][Full Text] [Related]
12. Improving antibody affinity by mimicking somatic hypermutation in vitro.
Chowdhury PS; Pastan I
Nat Biotechnol; 1999 Jun; 17(6):568-72. PubMed ID: 10385321
[TBL] [Abstract][Full Text] [Related]
13. Generation of anti-p53 Fab fragments from individuals with colorectal cancer using phage display.
Coomber DW; Hawkins NJ; Clark MA; Ward RL
J Immunol; 1999 Aug; 163(4):2276-83. PubMed ID: 10438972
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen.
Yan X; Evans SV; Kaminki MJ; Gillies SD; Reisfeld RA; Houghton AN; Chapman PB
J Immunol; 1996 Aug; 157(4):1582-8. PubMed ID: 8759742
[TBL] [Abstract][Full Text] [Related]
15. Tolerance of single, but not multiple, amino acid replacements in antibody VH CDR 2: a means of minimizing B cell wastage from somatic hypermutation?
Brown M; Rittenburg MB; Chen C; Roberts VA
J Immunol; 1996 May; 156(9):3285-91. PubMed ID: 8617951
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
17. Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis.
Yelton DE; Rosok MJ; Cruz G; Cosand WL; Bajorath J; Hellström I; Hellström KE; Huse WD; Glaser SM
J Immunol; 1995 Aug; 155(4):1994-2004. PubMed ID: 7636250
[TBL] [Abstract][Full Text] [Related]
18. Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten.
Sharon J; Gefter ML; Wysocki LJ; Margolies MN
J Immunol; 1989 Jan; 142(2):596-601. PubMed ID: 2911012
[TBL] [Abstract][Full Text] [Related]
19. Use of phage surface expression to analyze regions of human V4-34(VH4-21)-encoded IgG autoantibody required for recognition of DNA: no involvement of the 9G4 idiotope.
Mockridge CI; Chapman CJ; Spellerberg MB; Isenberg DA; Stevenson FK
J Immunol; 1996 Sep; 157(6):2449-54. PubMed ID: 8805644
[TBL] [Abstract][Full Text] [Related]
20. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
